海外の治験の状況「1」での検索結果
2657件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer
- Estrogen Receptor Negative;Estrogen Receptor Positive;HER2/Neu Negative;Male Breast Carcinoma;Progesterone Receptor Negative;Recurrent Breast Carcinoma;Stage IIIC Breast Cancer AJCC v7;Stage IV Breast Cancer AJCC v6 and v7;Triple-Negative Breast Carcinoma;Estrogen Receptor Negative;Estrogen Receptor Positive;HER2/Neu Negative;Male Breast Carcinoma;Progesterone Receptor Negative;Recurrent Breast Carcinoma;Stage IIIC Breast Cancer AJCC v7;Stage IV Breast Cancer AJCC v6 and v7;Triple-Negative Breast Carcinoma;Estrogen Receptor Negative;Estrogen Receptor Positive;HER2/Neu Negative;Male Breast Carcinoma;Progesterone Receptor Negative;Recurrent Breast Carcinoma;Stage IIIC Breast Cancer AJCC v7;Stage IV Breast Cancer AJCC v6 and v7;Triple-Negative Breast Carcinoma
- Australia, China, Singapore, United States
- 2011-05-06
Not Recruiting
- A Comparative study between distal and proximal ultrasound guided bilateral occipital nerve block for post dural puncture headache
- Nervous System Diseases To compare the pain relieving effect of ultrasound guided bilateral greater occipital nerve block at superior nuchal line versus at C2 level for post dural puncture headache.;Nervous System Diseases;To compare the pain relieving effect of ultrasound guided bilateral greater occipital nerve block at superior nuchal line versus at C2 level for post dural puncture headache.
- Egypt
- 2018-04-04
Not recruiting
- Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase;Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase;Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Egypt
- 2018-02-26
Not Recruiting
- Clinical study investigating pharmacokinetic properties of BT524 and efficacy and safety of BT524 in the treatment and prophylaxis of bleeding in patients with congenital fibrinogen deficiency
- Patients with congenital afibrinogenemia or severe congenital hypofibrinogenemia. MedDRA version: 14.1 Level: PT Classification code 10016075 Term: Factor I deficiency System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Egypt, Germany, Italy, Lebanon
- 2013-02-20
Not Recruiting
- A 52 week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects with Crohn’s Disease
- Subjects with Crohn's Disease MedDRA version: 16.0 Level: PT Classification code 10011401 Term: Crohn's disease System Organ Class: 10017947 - Gastrointestinal disorders ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Norway, Poland, Portugal, Russian Federation, Slovakia, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States
- 2010-10-29
Not recruiting
- Minoxidil Response Testing in Females With Female Pattern Hair Loss
- Alopecia;Female Pattern Hair Loss;Alopecia;Female Pattern Hair Loss
- Australia, India, Italy, United States
- 2014-07-31
Not Recruiting
- Dexmedetomidine versus Fentanyl on Intubation Stress Responses in Pre-eclamptic patients undergoing Caesarean delivery.
- Pregnancy and Childbirth Surgery pre- eclampsia, caesarean delivery;Pregnancy and Childbirth;Surgery;pre- eclampsia, caesarean delivery
- Egypt
- 2015-07-12
Recruiting
- The (i)mpact of (H)igh (I)ntensity intermittent (T)raining on health and mechanisms of insulin resistance in women with (P)oly(c)ystic (O)vary (S)yndrome: The iHIT-PCOS randomised control trial.
- Polycystic Ovary Syndrome ;Insulin Resistance;Obesity;Menstrual disturbances and ovulation ;Depression ;Polycystic Ovary Syndrome Health related quality of life;Barriers and facilitators to physical activity
- Australia
- 2015-03-17
Recruiting
- A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Infantile-onset Spinal Muscular Atrophy
- Spinal Muscular Atrophy;G12.0 - Infantile spinal muscular atrophy, type I [Werdnig-Hoffman];G12.1 - Other inherited spinal muscular atrophy
- Australia, Canada, France, Germany, Hong Kong, Italy, Japan, Korea, Republic of, Spain, Sweden, Taiwan, Province of China, United Kingdom, United States
- 2016-09-12
Not Recruiting
- An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc.
- HIV-1 infection MedDRA version: 17.1 Level: LLT Classification code 10020192 Term: HIV-1 System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Argentina, Belgium, Italy, Poland, Russian Federation, South Africa, Switzerland, Thailand
- 2012-01-31
Not Recruiting
- Effect of immunitum supplementation on prevention of recurrent infectious episodes in children with moderate malnutrition: a randomised, double-blind, placebo-controlled trial
- Recurrent infectious diseases in children with malnutrition: 1. ENT sphere infections 2. Broncho-pulmonary infections 3. Gastrointestinal tract infections 4. Malaria Infections and Infestations 1. ENT sphere infections 2. Broncho-pulmonary infections 3. Gastrointestinal tract infections 4. Malaria
- Rwanda
- 2017-07-04
Authorised
- Research study to determine whether an investigational drug, SHP647, is safe and effective in the treatment of moderate to severe Crohn’s Disease, compared with placebo (dummy treatment) – using a randomised and blinded study design (investigator and patients are not aware whether they receive study drug or placebo.
- Crohn's disease MedDRA version: 20.0 Level: LLT Classification code 10011402 Term: Crohn's disease (colon) System Organ Class: 100000004856 ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Colombia, Croatia, Czech Republic, Estonia, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Lithuania, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Switzerland, Ukraine, United Kingdom, United States
- 2018-05-02
Authorised
- Research study to determine whether an investigational drug, SHP647, is safe and effective in the treatment of moderate to severe Crohn's Disease, compared with placebo (dummy treatment) – using a randomised and blinded study design (investigator and patients are not aware whether they receive study drug or placebo)
- Crohn's disease MedDRA version: 20.0 Level: PT Classification code 10011401 Term: Crohn's disease System Organ Class: 10017947 - Gastrointestinal disorders ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Australia, Austria, Brazil, Croatia, Czech Republic, Germany, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Russian Federation, Serbia, South Africa, United Kingdom, United States
- 2018-04-19
Authorised
- Research study to determine whether an investigational drug, SHP647, is safe and effective in the treatment of moderate to severe Crohn’s Disease, compared with placebo (dummy treatment) – using a randomised and blinded study design (investigator and patients are not aware whether they receive study drug or placebo.
- Crohn's disease MedDRA version: 20.0 Level: LLT Classification code 10011402 Term: Crohn's disease (colon) System Organ Class: 100000004856 ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Colombia, Croatia, Czech Republic, Estonia, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Lithuania, Mexico, Netherlands, Poland, Portugal, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Switzerland, Ukraine, United Kingdom, United States
- 2018-04-19
Authorised
- Research study to determine whether an investigational drug, SHP647, is safe and effective in the treatment of moderate to severe Crohn’s Disease, compared with placebo (dummy treatment) – using a randomised and blinded study design (investigator and patients are not aware whether they receive study drug or placebo.
- Crohn's disease MedDRA version: 20.0 Level: LLT Classification code 10011402 Term: Crohn's disease (colon) System Organ Class: 100000004856 ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Colombia, Croatia, Czech Republic, Estonia, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Lithuania, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Switzerland, Ukraine, United Kingdom, United States
- 2018-04-17
Not Available
- Research study to determine whether an investigational drug, SHP647, is safe and effective in the treatment of moderate to severe Crohn’s Disease, compared with placebo (dummy treatment) – using a randomised and blinded study design (investigator and patients are not aware whether they receive study drug or placebo.
- Crohn's disease MedDRA version: 20.0 Level: LLT Classification code 10011402 Term: Crohn's disease (colon) System Organ Class: 100000004856 ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Colombia, Croatia, Czech Republic, Estonia, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Lithuania, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Switzerland, Ukraine, United Kingdom, United States
- 2018-04-10
Not recruiting
- Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease
- Motor Neuron Disease;Amyotrophic Lateral Sclerosis
- Australia
- 2018-03-09
Not Recruiting
- A La CaRT: Australasian Laparoscopic Cancer of the Rectum Trial A phase III prospective randomised trial comparing laparoscopic-assisted resection versus open resection for rectal cancer
- The study compares two types of surgery for rectal cancer stage T 0-3, N 0-1, M 0-laparoscopic-assisted resection versus open resection; The study compares two types of surgery for rectal cancer stage T 0-3, N 0-1, M 0-laparoscopic-assisted resection versus open resection;Cancer - Bowel - Back passage (rectum) or large bowel (colon)
- Australia, New Zealand
- 2009-08-05
Not Recruiting
- A randomized, double-blind, placebo-controlled, parallel group, multi-centre study to investigate the safety and efficacy of CP-690,550 for maintenance therapy in subjects with moderate to severe Crohn’s disease
- Crohn's disease MedDRA version: 17.1 Level: LLT Classification code 10011402 Term: Crohn's disease (colon) System Organ Class: 100000004856 ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Australia, Austria, Bulgaria, Canada, Croatia, Czech Republic, France, Germany, Greece, Hungary, Israel, Japan, Korea, Republic of, Netherlands, South Africa, Spain, Sweden, Ukraine, United States
- 2011-10-17
Recruiting
- Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
- Charcot-Marie-Tooth Disease, Type Ia (Disorder);HMSN
- Australia, Italy, United Kingdom, United States
- 2010-08-09